// App-Quantinova.ai

e20545 : EGFR mutation detection in plasma of lung tumor patients to predict success in treatment with tyrosine kinase inhibitors in a routine clinical setting.

Researchers

Presenter

  • Marc G. Denis

Principal Investigators

  • Stephanie Bordenave

  • Anne-Marie Chiappa

  • Philippe Masson

  • Clarisse Audigier-Valette

  • Herve Lacroix

  • Claire Alizon

  • Bertrand Guy

  • Isabelle Caby

  • Thierry Chatellier

  • Valerie Delecroix

  • Thierry Jeanfaivre

  • Marie Marcq

  • Thierry Pigeanne

  • Gilles Quere

  • Roland Schott

  • Thierry Urban

  • Sandrine Theoleyre

  • Audrey Vallee

Medical Centers

  • Nantes University Hospital, Nantes, France

  • ICO Rene Gauducheau, Nantes, France

  • C.H. Cornouaille, Quimper, France

  • Centre Hospitalier De Cholet, Cholet, France

  • Service de Pneumologie - CH Toulon, Toulon, France

  • Hotel Dieu - CHU, Nantes, France

  • CH Cholet, Cholet, France

  • Cabinet Pneumologie, Reims, France

  • CHD, La Roche Sur Yon, France

  • Clinique Mutualiste de l'Estuaire - Cite Sanitaire, Saint Nazaire, France

  • Centre Etienne Dolet, Saint-Nazaire, France

  • CHU, Angers, France

  • Centre Hospitalier, La Roche-sur-Yon, France

  • CH, Les Sables D'olonnes, France

  • CHU Morvan, Brest, France

  • Paul Strauss Cancer Center, Strasbourg, France

  • CHU Angers University, Angers, France

  • Department of Biochemistry, Nantes University Hospital, Nantes, France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Lung Cancer

Biomarkers

  • Epidermal growth factor receptor

  • Plasma cell-free DNA

Drug/Treatment

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved